Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 25
Study Finds Rheumatoid Arthritis Drugs Triple Patient Cancer Risk
Arthritis Drugs - Issue: 24
Arthritis Drugs in the Medical Literature This Month - May 2006
Arthritis Drugs - Issue: 25
Merck Says New Data Show No Added Risk after Stopping Vioxx Use
N.J. Judge Delays Man's Vioxx Trial; Another Still Set for June
Arthritis Drugs - Issue: 24
Expert Witness Lists Disclosed for First Calif. Vioxx Trial
FDA Ordered to Produce Documents Not Under Deliberative Process Privilege
Judge Denies 'Learned Intermediary' Protection to Illinois Pharmacies
Merck Seeks Sanctions for Plaintiffs' Failure to Timely File Fact Sheets
